Therapeutic uses of abarelix
US6197337A · kind A · utility
2Cited by
3References
4Claims
0Family size
Inventors
Key dates
| Filing date | May 9, 2000 |
| Grant date | Mar 6, 2001 |
| Priority date | — |
| Expiry date | May 9, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease wherein the method involves administering to a human or an animal an amount of abarelix sufficient to reduce atherosclerosis and its complications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.